| Product Name | MF | CAS | Details |
|---|
| Alantolactone | C15H20O2 | 546-43-0 | Details |
| Cenisertib | C24H30FN7O | 871357-89-0 | Details |
| AZD1208 | C21H21N3O2S | 1204144-28-4 | Details |
| Ochromycinone | C19H14O4 | 111540-00-2 | Details |
| M-110 | C22H28ClN5O3 | 1395048-49-3 | Details |
| GDC-0339 | C20H22F3N7OS | 1428569-85-0 | Details |
| Erlotinib D6 hydrochloride | C22H18ClD6N3O4 | 1189953-78-3 | Details |
| Ilginatinib maleate | C25H24FN7O4 | 1354799-87-3 | Details |
| Lifirafenib | C25H17F3N4O3 | 1446090-79-4 | Details |
| NRC-2694 | C24H26N4O3 | 936446-61-6 | Details |
| (Rac)-JBJ-04-125-02 | C29H26FN5O3S | 2140807-05-0 | Details |
| Osimertinib dimesylate | C29H37N7O5S | 2070014-82-1 | Details |
| RTC-5 | C24H22ClF3N2O3S | 1423077-49-9 | Details |
| STAT3-IN-3 | C27H26BrN3O6S | 2361304-26-7 | Details |
| Lapatinib ditosylate | C36H34ClFN4O7S2 | 388082-77-7 | Details |
| Gefitinib hydrochloride | C22H25Cl2FN4O3 | 184475-55-6 | Details |
| CX-6258 | C26H24ClN3O3 | 1202916-90-2 | Details |
| AG-825 | C19H15N3O3S2 | 149092-50-2 | Details |
| Ilginatinib hydrochloride | C21H21ClFN7 | 1239358-85-0 | Details |
| Mavelertinib | C18H22FN9O2 | 1776112-90-3 | Details |
| CHZ868 | C22H19F2N5O2 | 1895895-38-1 | Details |
| Almonertinib | C30H35N7O2 | 1899921-05-1 | Details |
| AS2863619 | C16H13ClN8O | 2241300-51-4 | Details |
| UC-514321 | C26H35NO5 | 299420-83-0 | Details |
| Tyrphostin AG30 | C10H7NO4 | 122520-79-0 | Details |
| Protosappanin A | C15H12O5 | 102036-28-2 | Details |
| Lavendustin A | C21H19NO6 | 125697-92-9 | Details |
| NSC 74859 | C16H15NO7S | 501919-59-1 | Details |
| Icotinib Hydrochloride | C22H22ClN3O4 | 1204313-51-8 | Details |
| Mutated EGFR-IN-1 | C25H31N7O | 1421372-66-8 | Details |
| Homoharringtonine | C29H39NO9 | 26833-87-4 | Details |
| Tarloxotinib bromide | C24H24Br2ClN9O3 | 1636180-98-7 | Details |
| Tyrphostin 23 | C10H6N2O2 | 118409-57-7 | Details |
| JND3229 | C33H41ClN8O2 | 2260886-64-2 | Details |
| Diosgenin | C27H42O3 | 512-04-9 | Details |
| Neratinib | C30H29ClN6O3 | 698387-09-6 | Details |
| Artesunate | C19H28O8 | 88495-63-0 | Details |
| Rociletinib hydrobromide | C27H29BrF3N7O3 | 1446700-26-0 | Details |
| GLPG0634 analog | C23H18N6O2 | 1206101-20-3 | Details |
| Gefitinib-based PROTAC 3 | C47H57ClFN7O8S | 2230821-27-7 | Details |
| Lestaurtinib | C26H21N3O4 | 111358-88-4 | Details |
| G5-7 | C22H19F2NO3 | 939681-36-4 | Details |
| CK2/ERK8-IN-1 | C11H9Br4N3O2 | 1085822-09-8 | Details |
| Niclosamide olamine | C15H15Cl2N3O5 | 1420-04-8 | Details |
| PKI-166 | C20H18N4O | 187724-61-4 | Details |
| Cryptotanshinone | C19H20O3 | 35825-57-1 | Details |
| CX-6258 hydrochloride hydrate | C26H27Cl2N3O4 | 1353858-99-7 | Details |
| Gefitinib D8 | C22H24ClFN4O3 | 857091-32-8 | Details |
| Nitidine chloride | C21H18NO4+ | 13063-04-2 | Details |
| Almonertinib hydrochloride | C30H36ClN7O2 | 2134096-03-8 | Details |
| SC99 | C15H8Cl2FN3O | 882290-02-0 | Details |
| AG-1478 | C16H14ClN3O2 | 153436-53-4 | Details |
| Curculigoside | C22H26O11 | 85643-19-2 | Details |
| JAK2-IN-6 | C14H10ClN3OS2 | 353512-04-6 | Details |
| TCS PIM-1 1 | C18H11BrN2O2 | 491871-58-0 | Details |
| Napabucasin | C14H8O4 | 83280-65-3 | Details |
| Khellin | C14H12O5 | 82-02-0 | Details |
| Cerdulatinib hydrochloride | C20H28ClN7O3S | 1369761-01-2 | Details |
| Itacitinib adipate | C32H33F4N9O5 | 1334302-63-4 | Details |
| Zorifertinib | C22H23ClFN5O3 | 1626387-80-1 | Details |
| PF-06459988 | C19H22ClN7O3 | 1428774-45-1 | Details |
| EGFR-IN-8 | C32H23ClF3N7O4 | 2407957-87-1 | Details |
| SHR0302 | C18H22N8O2S | 1445987-21-2 | Details |
| RGB-286638 | C29H37Cl2N7O4 | 784210-87-3 | Details |
| CX-6258 hydrochloride | C26H25Cl2N3O3 | 1353859-00-3 | Details |
| BD750 | C14H13N3OS | 892686-59-8 | Details |
| JAK3-IN-1 | C26H30ClN7O2 | 1805787-93-2 | Details |
| Naquotinib mesylate | C31H46N8O6S | 1448237-05-5 | Details |
| JAK/HDAC-IN-1 | C19H21Cl2N7O2 | 2284621-75-4 | Details |
| SI-109 | C40H44F2N7O9P | 2429877-30-3 | Details |
| Baricitinib phosphate | C16H20N7O6PS | 1187595-84-1 | Details |
| Mutant EGFR inhibitor | C27H30ClN7O2 | 1421373-62-7 | Details |
| EGFR-IN-3 | C29H28F2N6O2 | 1660963-42-7 | Details |
| PIM-447 dihydrochloride | C24H23F3N4O | 1820565-69-2 | Details |
| Mobocertinib | C32H39N7O4 | 1847461-43-1 | Details |
| Mobocertinib succinate | C36H45N7O8 | 2389149-74-8 | Details |
| EGFR-IN-11 | C29H35N9O2S | 2463200-44-2 | Details |
| EMI56 | C21H20N2O3 | 2414374-41-5 | Details |
| Tephrosin | C23H22O7 | 76-80-2 | Details |
| SGI-1776 | C20H22F3N5O | 1025065-69-3 | Details |
| Tesevatinib | C24H25Cl2FN4O2 | 781613-23-8 | Details |
| Ruxolitinib (S enantiomer) | C17H18N6 | 941685-37-6 | Details |
| Osimertinib mesylate | C29H37N7O5S | 1421373-66-1 | Details |
| Ilginatinib | C21H20FN7 | 1239358-86-1 | Details |
| Oclacitinib maleate | C19H27N5O6S | 1640292-55-2 | Details |
| Tarlox-TKI | C19H18BrClN6O | 2135696-72-7 | Details |
| JCN037 | C16H11BrFN3O2 | 2305154-31-6 | Details |
| Afatinib impurity 11 | C21H18ClFN4O3 | 1402086-20-7 | Details |
| Scutellarin | C21H18O12 | 27740-01-8 | Details |
| Cyasterone | C29H44O8 | 17086-76-9 | Details |
| CP-724714 | C27H27N5O3 | 383432-38-0 | Details |
| BMS-599626 Hydrochloride | C27H28ClFN8O3 | 873837-23-1 | Details |
| Corylifol A | C25H26O4 | 775351-88-7 | Details |
| SH-4-54 | C29H27F5N2O5S | 1456632-40-8 | Details |
| Avitinib maleate | C30H30FN7O6 | 1557268-88-8 | Details |
| CCT365623 hydrochloride | C18H18ClNO4S3 | 2126136-98-7 | Details |
| NVP-BSK805 dihydrochloride | C27H29ClF2N6O | 1942919-79-0 | Details |
| PF-06700841 P-Tosylate | C25H29F2N7O4S | 2140301-96-6 | Details |
| AS2863619 free base | C16H12N8O | 2241300-50-3 | Details |
| Chrysophanol | C15H10O4 | 481-74-3 | Details |
| Product Total： Product Page： | ||||
| 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 | ||||